US Patent

US10940157 — System for providing birth control

Formulation · Assigned to Population Council Inc · Expires 2039-06-21 · 13y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a vaginal system containing segesterone acetate and ethinyl estradiol for use in thirteen 28-day product-use cycles.

USPTO Abstract

The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.

Drugs covered by this patent

Patent Metadata

Patent number: US10940157
Jurisdiction: US
Classification: Formulation
Expires: 2039-06-21
Drug substance claim: No
Drug product claim: Yes
Assignee: Population Council Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.